Hideki Yasui

2.5k total citations
113 papers, 1.2k citations indexed

About

Hideki Yasui is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, Hideki Yasui has authored 113 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pulmonary and Respiratory Medicine, 37 papers in Physiology and 19 papers in Oncology. Recurrent topics in Hideki Yasui's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (45 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (24 papers) and Asthma and respiratory diseases (16 papers). Hideki Yasui is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (45 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (24 papers) and Asthma and respiratory diseases (16 papers). Hideki Yasui collaborates with scholars based in Japan, United States and Spain. Hideki Yasui's co-authors include Takafumi Suda, Naoki Inui, Tomoyuki Fujisawa, Noriyuki Enomoto, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Hironao Hozumi, Yutaro Nakamura and Masato Kono and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hideki Yasui

101 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideki Yasui Japan 21 777 366 249 160 147 113 1.2k
Argyrios Tzouvelekis Greece 20 1.4k 1.8× 342 0.9× 169 0.7× 176 1.1× 342 2.3× 89 1.8k
Francesco Salton Italy 20 1.0k 1.3× 225 0.6× 197 0.8× 163 1.0× 265 1.8× 81 1.6k
Magnus Sköld Sweden 18 498 0.6× 203 0.6× 112 0.4× 114 0.7× 171 1.2× 77 1.0k
Rosa Metella Refini Italy 26 1.2k 1.6× 854 2.3× 165 0.7× 157 1.0× 189 1.3× 72 1.8k
Rafael L. Perez United States 14 477 0.6× 190 0.5× 214 0.9× 149 0.9× 179 1.2× 41 1.2k
Francesco Varone Italy 18 1.1k 1.5× 303 0.8× 145 0.6× 62 0.4× 150 1.0× 62 1.4k
Catherine Moermans Belgium 21 701 0.9× 448 1.2× 110 0.4× 202 1.3× 287 2.0× 60 1.2k
Miriana d’Alessandro Italy 24 1.1k 1.4× 617 1.7× 235 0.9× 303 1.9× 268 1.8× 156 1.9k
Jan C. Grutters Netherlands 23 1.6k 2.1× 1.1k 2.9× 227 0.9× 114 0.7× 232 1.6× 63 2.0k
Eleni Tzortzaki Greece 25 881 1.1× 471 1.3× 98 0.4× 147 0.9× 291 2.0× 58 1.4k

Countries citing papers authored by Hideki Yasui

Since Specialization
Citations

This map shows the geographic impact of Hideki Yasui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Yasui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Yasui more than expected).

Fields of papers citing papers by Hideki Yasui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Yasui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Yasui. The network helps show where Hideki Yasui may publish in the future.

Co-authorship network of co-authors of Hideki Yasui

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Yasui. A scholar is included among the top collaborators of Hideki Yasui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Yasui. Hideki Yasui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Miyashita, Koichi, Hironao Hozumi, Eiji Nakatani, et al.. (2025). Outcomes of COVID-19 in the Omicron-predominant wave: large-scale real-world data analysis with a comparison to influenza. PubMed. 17(1). 3–3.
3.
Inoue, Yusuke, Masato Karayama, Hideki Yasui, et al.. (2025). Massive immune-related myositis and cytokine release syndrome during dual immunotherapy plus chemotherapy for recurrent lung adenocarcinoma: case report. Respiratory Medicine Case Reports. 58. 102304–102304.
4.
Miyashita, Koichi, Hironao Hozumi, Eiji Nakatani, et al.. (2024). Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study. Respiratory Research. 25(1). 95–95. 3 indexed citations
5.
Watanabe, Hirofumi, Yusuke Inoue, Masato Karayama, et al.. (2024). Characterization of BRAFThr599dup Mutation as a Targetable Driver Mutation Identified in Lung Adenocarcinoma by Comprehensive Genomic Profiling. JCO Precision Oncology. 8(8). e2300538–e2300538.
6.
Suzuki, Yuzo, Ryo Horiguchi, Yuya Aono, et al.. (2024). CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling. The Journal of Immunology. 212(7). 1221–1231. 3 indexed citations
7.
Suzuki, Yuzo, Masato Kono, Hirotsugu Hasegawa, et al.. (2023). Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis. Respirology. 28(8). 775–783. 23 indexed citations
8.
Enomoto, Noriyuki, Hironao Hozumi, Yuya Aono, et al.. (2021). Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis. Respiratory Investigation. 59(6). 827–836. 17 indexed citations
9.
Karayama, Masato, Yusuke Inoue, Hideki Yasui, et al.. (2021). Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy. BMC Pulmonary Medicine. 21(1). 409–409. 17 indexed citations
10.
Fujisawa, Tomoyuki, Ryoko Egashira, Hiromitsu Sumikawa, et al.. (2021). Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias. Respiratory Research. 22(1). 290–290. 10 indexed citations
11.
Karayama, Masato, Naoki Inui, Hideki Yasui, et al.. (2020). Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations. Investigational New Drugs. 39(1). 210–216. 6 indexed citations
12.
13.
Hozumi, Hironao, Hideki Yasui, Yuzo Suzuki, et al.. (2019). Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias. Respiratory Medicine. 154. 102–108. 9 indexed citations
14.
Suzuki, Yuzo, Koushi Yokomura, Masahiro Shirai, et al.. (2019). Body composition changes successfully classify prognosis in patients with mycobacterium avium complex lung disease. Journal of Infection. 79(4). 341–348. 10 indexed citations
15.
Fujisawa, Tomoyuki, Kazutaka Mori, Hideki Yasui, et al.. (2018). IL-17A Attenuates IFN-λ Expression by Inducing Suppressor of Cytokine Signaling Expression in Airway Epithelium. The Journal of Immunology. 201(8). 2392–2402. 21 indexed citations
16.
Karayama, Masato, Naoki Inui, Hideki Yasui, et al.. (2018). Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysis. Medical Oncology. 35(11). 139–139. 4 indexed citations
17.
Inui, Naoki, Hironao Hozumi, Yusuke Inoue, et al.. (2018). Neutrophil gelatinase-associated lipocalin in patients with sarcoidosis. Respiratory Medicine. 138. S20–S23. 5 indexed citations
18.
Yasui, Hideki, et al.. (2018). Direct pulmonary infiltrates as an initial manifestation of chronic lymphocytic leukemia. Respiratory Medicine Case Reports. 25. 282–285. 2 indexed citations
19.
Yasui, Hideki, Naoki Inui, Masato Karayama, et al.. (2018). Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease. Respiratory Medicine. 146. 76–80. 9 indexed citations
20.
Inui, Naoki, Hideki Yasui, Masato Kono, et al.. (2014). Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics. 30. 11–15. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Argyrios Tzouvelekis Breakdown of academic impact, for papers by Francesco Salton Breakdown of academic impact, for papers by Magnus Sköld Breakdown of academic impact, for papers by Rosa Metella Refini Breakdown of academic impact, for papers by Rafael L. Perez Breakdown of academic impact, for papers by Francesco Varone Breakdown of academic impact, for papers by Catherine Moermans Breakdown of academic impact, for papers by Miriana d’Alessandro Breakdown of academic impact, for papers by Jan C. Grutters Breakdown of academic impact, for papers by Eleni Tzortzaki
Rankless by CCL
2026